Login
Align Technology Inc logo

Align Technology Inc

aligntech.com

Align Technology (NASDAQ: ALGN) is a medical device company that designs, manufactures, and sells clear dental aligners and intraoral scanners. Revenue comes primarily from the sale of Invisalign clear aligner products to orthodontists and dentists, alongside sales of iTero intraoral scanning systems. The company operates globally, with customers across North America, Europe, and international markets. Align was incorporated and has its principal executive offices in the United States. The 10-K filed February 27, 2026 covers the fiscal year ended December 31, 2025. Product lines include Invisalign clear aligners and iTero scanners, serving dental and orthodontic professionals as the primary customer base. The business sells capital equipment in scanners and consumable-style treatment cases in aligners, creating a transactional revenue model tied to case volume submitted by doctors. Geographic and segment revenue breakdowns are not fully detailed in the available filing excerpts.

Products & Services

Invisalign clear aligners, iTero intraoral scanners. Additional products mentioned include other clear aligners and related dental products per the FY2025 10-K.

Revenue Model

Transactional sales of Invisalign clear aligner cases submitted by orthodontist and dentist customers, plus capital equipment sales of iTero intraoral scanners. Revenue is case-volume driven on the aligner side and unit-sales driven on the scanner side.

Customers & Markets

Orthodontists and general practice dentists. End market is dental and orthodontic treatment for consumers. Customers are licensed dental professionals who submit cases and purchase scanning equipment.

Geographic Exposure

Global operations including North America, Europe, and international markets. Operations and assets noted in Israel and Russia per FY2025 10-K risk disclosures.

Financial Snapshot

Revenue
TTM
$4.140B
Gross Margin
TTM
68.01%
Net Income
TTM
$413.6M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
139.53%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$4.232B
Cash
2026 Q2
P/E
TTM
27.92
Free Cash Flow
TTM
$633.6M

Stock Price

Loading...
Market Cap: $11.548 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support